Last reviewed · How we verify
NCT05325398: EMoHyNAFLD
Effect of Molecular Hydrogen in Patients With NAFLD
NA trial testing HRW drink, HRW Natural Health Products Inc., Made in Vancouver, Canada in Non-Alcoholic Fatty Liver Disease in 30 participants. Completed in 18 December 2020.
1 December 2020
Quick facts
| Lead sponsor | Comenius University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 May 2020 |
| Primary completion | 1 December 2020 |
| Estimated completion | 18 December 2020 |
| Sites | 1 location across Slovakia |
Drugs / interventions tested
- HRW drink, HRW Natural Health Products Inc., Made in Vancouver, Canada
- placebo
Conditions studied
- Non-Alcoholic Fatty Liver Disease — all drugs for Non-Alcoholic Fatty Liver Disease →
Sponsor
Comenius University
Who can join
Adults 33 to 69, any sex, with Non-Alcoholic Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Molecular hydrogen H2 acts as antioxidant which selectively reduces cytotoxic harmful reactive oxygen species ROS and concomitantly acts as biological messenger, which mediates several signaling pathways that play cytoprotective role in many human diseases. Due to their small size and high permeability, H2 is easily transportable into subcellular structures as mitochondria.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside.
Xie F, Song Y, Yi Y, Jiang X, et al · · 2023 · cited 16× · PMID 37111299 · DOI 10.3390/ph16040541
Verify or expand the search:
- PubMed search for NCT05325398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Non-Alcoholic Fatty Liver Disease
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07294963 — Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease · NA · recruiting
- NCT07130318 — Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise · NA · recruiting
- NCT06355310 — Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease · Phase 2 · recruiting
- NCT06863376 — Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients · Phase 2 · recruiting
Other Comenius University trials
Trials by the same sponsor.
- NCT07522905 — Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission · NA · not yet recruiting
- NCT07446556 — Exercise Program in Women With Pudendal Neuralgia · NA · enrolling by invitation
- NCT07465809 — Mental Health Resources and Employability in Healthcare · NA · completed
- NCT07442838 — Clinical Outcomes and Complications in Two-stage Breast Reconstruction Using Microtextured and Nanotextured Expanders · active not recruiting
- NCT06842615 — Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients With Suspected or Confirmed Mac · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05325398 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Comenius University
- Last refreshed: 13 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05325398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing